Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Panacea Life Sciences's revenue for the twelve months ending Mar 31, 2024 was $2.76M, up 50.4% year over year. For fiscal 2023 it was $2.38M, up 46.6% from the year before. The highest annual figure on record is $9.02M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.38M | +46.6% |
| FY2022 | Dec 31, 2022 | $1.63M | -21.0% |
| FY2021 | Dec 31, 2021 | $2.06M | -77.2% |
| FY2020 | Dec 31, 2020 | $9.02M | +2508.7% |
| FY2019 | Dec 31, 2019 | $345.68K | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $213 | -75.0% |
| FY2014 | Dec 31, 2014 | $852 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | $1.06M | +55.9% |
| Q4 FY2023 | Dec 31, 2023 | $960.50K | +195.7% |
| Q3 FY2023 | Sep 30, 2023 | $347.85K | -5.0% |
| Q2 FY2023 | Jun 30, 2023 | $399.13K | -15.0% |
| Q1 FY2023 | Mar 31, 2023 | $677.48K | +45.2% |
| Q4 FY2022 | Dec 31, 2022 | $324.79K | -49.7% |
| Q3 FY2022 | Sep 30, 2022 | $366.24K | -37.7% |
| Q2 FY2022 | Jun 30, 2022 | $469.47K | +49.8% |
| Q1 FY2022 | Mar 31, 2022 | $466.47K | -8.9% |
| Q4 FY2021 | Dec 31, 2021 | $645.95K | -9.3% |
| Q3 FY2021 | Sep 30, 2021 | $588.04K | -56.2% |
| Q2 FY2021 | Jun 30, 2021 | $313.50K | -94.9% |
| Q1 FY2021 | Mar 31, 2021 | $512.14K | -38.7% |
| Q4 FY2020 | Dec 31, 2020 | $712.09K | +448.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.34M | +2133.7% |
| Q2 FY2020 | Jun 30, 2020 | $6.16M | +10143.0% |
| Q1 FY2020 | Mar 31, 2020 | $836.00K | +5131.5% |
| Q4 FY2019 | Dec 31, 2019 | $129.86K | – |
| Q3 FY2019 | Sep 30, 2019 | $60.15K | – |
| Q2 FY2019 | Jun 30, 2019 | $60.15K | – |
| Q1 FY2019 | Mar 31, 2019 | $15.98K | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | -100.0% |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
| Q2 FY2016 | Jun 30, 2016 | $0 | -100.0% |
| Q1 FY2016 | Mar 31, 2016 | $0 | -100.0% |
| Q4 FY2015 | Dec 31, 2015 | $213 | 0.0% |
| Q1 FY2015 | Mar 31, 2015 | $0 | – |
| Q4 FY2014 | Dec 31, 2014 | $213 | – |
| Q3 FY2014 | Sep 30, 2014 | $213 | – |
| Q2 FY2014 | Jun 30, 2014 | $213 | – |
See a number that looks wrong?